Domperidone
CAS No. 57808-66-9
Domperidone( Motilium | NSC 299589 )
Catalog No. M15115 CAS No. 57808-66-9
Domperidone(Motilium) is a dopamine blocker and an antidopaminergic reagent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 50MG | 35 | In Stock |
|
| 100MG | 50 | In Stock |
|
| 200MG | 85 | In Stock |
|
| 500MG | 138 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDomperidone
-
NoteResearch use only, not for human use.
-
Brief DescriptionDomperidone(Motilium) is a dopamine blocker and an antidopaminergic reagent.
-
DescriptionDomperidone(Motilium) is a dopamine blocker and an antidopaminergic reagent. It blocks the action of. It has strong affinities for the D2 and D3 dopamine receptors, which are found in the chemoreceptor trigger zone, located just outside the blood brain barrier, which - among others - regulates nausea and vomiting (area postrema on the floor of the fourth ventricle and rhomboid fossa).(In Vitro):Cardiac Na+ channels are common targets of therapeutics inducing cardiotoxicity.Domperidone (0-1000 μM) displays concentration- and state-dependent inhibitory of Nav1.5 in Human embryonic kidney HEK293 cells.Domperidone (0, 10, 100 μM) displays tonic and use-dependent block to Na currents in rat cardiomyocytes with a IC50 of 312 μM.(In Vivo):Unlike Metoclopramide, Domperidone (R33812) does not cause any adverse neurological symptoms as it has minimal penetration through the blood-brain barrier.Domperidone acts as both an antiemetic and an upper gastrointestinal tract prokinetic agent. It is rapidly absorbed after oral administration, and few side effects have been reported.
-
In VitroCardiac Na+ channels are common targets of therapeutics inducing cardiotoxicity.Domperidone (0-1000 μM) displays concentration- and state-dependent inhibitory of Nav1.5 in Human embryonic kidney HEK293 cells. Domperidone (0, 10, 100 μM) displays tonic and use-dependent block to Na currents in rat cardiomyocytes with a IC50 of 312 μM.
-
In VivoUnlike Metoclopramide, Domperidone (R33812) does not cause any adverse neurological symptoms as it has minimal penetration through the blood-brain barrier.Domperidone acts as both an antiemetic and an upper gastrointestinal tract prokinetic agent. It is rapidly absorbed after oral administration, and few side effects have been reported.
-
SynonymsMotilium | NSC 299589
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorD2| D3
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number57808-66-9
-
Formula Weight425.92
-
Molecular FormulaC22H24ClN5O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 1 mg/mL (2.34 mM); DMSO: 48 mg/mL (112.69 mM)
-
SMILESO=C1NC2=CC(Cl)=CC=C2N1C3CCN(CCCN4C5=CC=CC=C5NC4=O)CC3
-
Chemical Name5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Freedman SB, et al. J Pharmacol Exp Ther. 1994 Jan;268(1):417-26.
molnova catalog
related products
-
Levodopa
L-DOPA is a natural form of DOPA used in the treatment of Parkinson disease.
-
CCT241736
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3.
-
Phenothiazine
Phenothiazine is a dopamine-2 (D2) receptor antagonist therefore decreases the effect of dopamine in the brain.
Cart
sales@molnova.com